|Epoch Biosciences fails to win DOD contract|
Friday September 26, 6:15 pm ET
LOS ANGELES, Sept 26 (Reuters) - Epoch Biosciences Inc. (NasdaqSC:EBIO - News), a provider of products that accelerate genomic analysis, on Friday said it did not win a U.S. Department of Defense contract for a biological agent identification system.
Epoch, based in Bothell, Washington, was a finalist in the competition for the program.
The company said it did not include revenue from the DOD project in its forecasts and its outlook for the fiscal year is unchanged.
Shares of Epoch fell 19 percent to close at $2.89 on Nasdaq